Company: NGVT
Filing Date: 2025-08-05
Form Type: 10-Q
Source: 0001653477-25-000108
Chunk: 108

Company: Ingevity Corp
Filing Date: 2025-08-05
Form: 10-Q
Item: Part I, Item 8
Chunk 108
---
.9 Advanced Polymer Technologies3.7 3.1 7.4 6.2 Total capital expenditures$12.2 $18.1 $22.2 $34.7 

26

INGEVITY CORPORATIONNotes to the Condensed Consolidated Financial StatementsJune 30, 2025(Unaudited)

Total assets In millionsJune 30, 2025December 31, 2024Performance Materials$853.2 $824.3 Performance Chemicals 558.2 567.1 Advanced Polymer Technologies (1)406.2 568.2 Total segment assets (2)$1,817.6 $1,959.6 Corporate and other60.1 63.0 Total assets$1,877.7 $2,022.6 _______________(1) The decline in the Advanced Polymer Technologies reportable segment in 2025, as compared to 2024, was driven by the Goodwill impairment charge. Refer to note 7 for more information.(2) Segment assets exclude assets not specifically managed as part of one specific segment herein referred to as "Corporate and other."

Note 15: Earnings (Loss) per Share

Three Months Ended June 30,Six Months Ended June 30,In millions (except share and per share data)2025202420252024Net income (loss) $(146.5)$(283.7)$(126.0)$(339.7)Basic and Diluted earnings (loss) per shareBasic earnings (loss) per share $(4.02)$(7.81)$(3.46)$(9.36)Diluted earnings (loss) per share (4.02)(7.81)(3.46)(9.36)Shares (in thousands)Weighted average number of common shares outstanding - Basic36,461 36,335 36,422 36,299 Weighted average additional shares assuming conversion of potential common shares— — — — Shares - diluted basis (1)36,461 36,335 36,422 36,299 _______________(1) For the three and six months ended June 30, 2025 and 2024, all potentially dilutive common shares were excluded from the calculation of diluted earnings (loss) per share as we had a net loss for the period. The following average number of potential common shares were antidilutive,